A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of AqualiefTM Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia
Simple Summary
Iacovelli, N.A.; Ingargiola, R.; Facchinetti, N.; Franceschini, M.; Romanello, D.A.; Bossi, P.; Bergamini, C.; Alfieri, S.; Cavalieri, S.; Baron, G.; Aldini, G.; Locati, L.; Orlandi, E. A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of AqualiefTM Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia. Cancers 2021, 13, 3456. https://doi.org/10.3390/cancers13143456
Iacovelli NA, Ingargiola R, Facchinetti N, Franceschini M, Romanello DA, Bossi P, Bergamini C, Alfieri S, Cavalieri S, Baron G, Aldini G, Locati L, Orlandi E. A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of AqualiefTM Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia. Cancers. 2021; 13(14):3456. https://doi.org/10.3390/cancers13143456
Chicago/Turabian StyleIacovelli, Nicola A., Rossana Ingargiola, Nadia Facchinetti, Marzia Franceschini, Domenico A. Romanello, Paolo Bossi, Cristiana Bergamini, Salvatore Alfieri, Stefano Cavalieri, Giovanna Baron, Giancarlo Aldini, Laura Locati, and Ester Orlandi. 2021. "A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of AqualiefTM Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia" Cancers 13, no. 14: 3456. https://doi.org/10.3390/cancers13143456